What is Biotium?
Biotium specializes in providing advanced fluorescent dyes, antibodies, and kits aimed at enhancing molecular and cellular biology research. Their extensive product range includes primary and secondary antibodies, protein labeling kits, and various reagents for applications in microbiology, neuroscience, and cancer research. The company serves a diverse clientele, including academic institutions and research laboratories, by offering innovative and reliable solutions for scientific exploration. With over 20 years of experience, Biotium is committed to supporting researchers with high-quality products and expert technical assistance, positioning itself as a key enabler of scientific discovery.
How much funding has Biotium raised?
Biotium has raised a total of $919K across 2 funding rounds:
Debt
$350K
Debt
$569K
Debt (2020): $350K with participation from PPP
Debt (2021): $569K led by PPP
What's next for Biotium?
The recent major strategic investment signals a pivotal phase for Biotium, likely enabling accelerated expansion of its research and development capabilities and the broadening of its product portfolio. This infusion of capital is expected to facilitate deeper penetration into existing markets and potentially open new avenues for application-specific solutions. As Biotium continues to innovate in the critical fields of molecular and cellular biology, this financing will be instrumental in supporting its mission to equip researchers with cutting-edge tools, further solidifying its role as a leader in the scientific research supply chain.
See full Biotium company page
